SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950123-09-023201
Filing Date
2009-07-17
Accepted
2009-07-17 16:31:07
Documents
2
Group Members
PROSPECT MANAGEMENT CO. III, L.L.C.PROSPECT VENTURE PARTNERS III, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G c88026sc13g.htm SC 13G 48934
2 EXHIBIT 99.1 c88026exv99w1.htm EX-99.1 3184
  Complete submission text file 0000950123-09-023201.txt   54101
Mailing Address 435 TASSO ST SUITE 200 PALO ALTO CA 94301
Business Address 435 TASSO ST SUITE 200 PALO ALTO CA 94301 650-327-8800
Prospect Venture Partners III L P (Filed by) CIK: 0001311490 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 420 STEVENS AVENUE SUITE 210 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 210 SOLANA BEACH CA 92075 (858) 480-0400
Somaxon Pharmaceuticals, Inc. (Subject) CIK: 0001339455 (see all company filings)

IRS No.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81290 | Film No.: 09951155
SIC: 2834 Pharmaceutical Preparations